Extracorporeal shock wave lithotripsy in pediatric patients using a late generation portable lithotriptor: experience

Caleb P Nelson1, David A Diamond, Marc Cendron

  • 1Department of Urology, Children's Hospital Boston and Harvard Medical School, Boston, Massachusetts, USA. caleb.nelson@childrens.harvard.edu

The Journal of Urology
|August 30, 2008
PubMed

Insights

Extracorporeal shock wave lithotripsy (ESWL) is effective for pediatric kidney stones, but success rates are lower in children with prior urological conditions or larger stones. Alternative treatments may be better for these complex cases.

Area of Science:

  • Pediatric Urology
  • Nephrology
  • Surgical Technology

Background:

  • Pediatric kidney stone incidence is rising.
  • Effective treatment modalities are crucial for children.
  • Extracorporeal shock wave lithotripsy (ESWL) is a key treatment option.

Purpose of the Study:

  • To evaluate contemporary ESWL outcomes in pediatric patients.
  • To identify factors influencing ESWL success in children.
  • To assess the safety and efficacy of ESWL in pediatric urolithiasis.

Main Methods:

  • Retrospective review of pediatric patients (<20 years) undergoing ESWL (1998-2007).
  • Utilized Dornier Compact Delta lithotriptor with ultrasound/fluoroscopic guidance.
  • Defined stone-free status by imaging within 12 months without further intervention.

Main Results:

  • Overall stone-free rate was 58.6% across 101 children (114 treatment sequences).
  • Lower success rates observed in children with prior urological conditions (12.5%) vs. those without (67%).
  • Larger stone size (>10 mm) and history of urological surgery negatively impacted stone-free rates.

Conclusions:

  • ESWL is effective and well-tolerated for many pediatric kidney stones.
  • Children with complex urological histories or large stones have reduced ESWL success.
  • Alternative treatment modalities should be considered for these specific pediatric populations.
Abstract